+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Female Fertility Rapid Tests - Medical Devices Pipeline Assessment, 2019

  • ID: 4856566
  • Report
  • November 2019
  • Region: Global
  • 44 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 3

FEATURED COMPANIES

  • BBB Technologies Inc
  • Bio-AMD Inc
  • ET Healthcare Inc
  • MFB Fertility Inc
  • NG Biotech
  • OPKO Health Inc
  • MORE
Female Fertility Rapid Tests - Medical Devices Pipeline Assessment, 2019

Summary
The author's Medical Devices sector report, “Female Fertility Rapid Tests - Medical Devices Pipeline Assessment, 2019 provides an overview of Female Fertility Rapid Tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Female Fertility Rapid Tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by the author's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Female Fertility Rapid Tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Female Fertility Rapid Tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to buy
The report enables you to:
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Female Fertility Rapid Tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • BBB Technologies Inc
  • Bio-AMD Inc
  • ET Healthcare Inc
  • MFB Fertility Inc
  • NG Biotech
  • OPKO Health Inc
  • MORE

1 Table of Contents

2 Introduction
2.1 Female Fertility Rapid Tests Overview

3 Products under Development
3.1 Female Fertility Rapid Tests - Pipeline Products by Stage of Development
3.2 Female Fertility Rapid Tests - Pipeline Products by Segment
3.3 Female Fertility Rapid Tests - Pipeline Products by Territory
3.4 Female Fertility Rapid Tests - Pipeline Products by Regulatory Path
3.5 Female Fertility Rapid Tests - Pipeline Products by Estimated Approval Date

4 Female Fertility Rapid Tests - Pipeline Products under Development by Companies
4.1 Female Fertility Rapid Tests Companies - Pipeline Products by Stage of Development
4.2 Female Fertility Rapid Tests - Pipeline Products by Stage of Development

5 Female Fertility Rapid Tests Companies and Product Overview
5.1 BBB Technologies Inc Company Overview
5.1.1 BBB Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
5.2 Bio-AMD Inc Company Overview
5.2.1 Bio-AMD Inc Pipeline Products & Ongoing Clinical Trials Overview
5.3 ET Healthcare Inc Company Overview
5.3.1 ET Healthcare Inc Pipeline Products & Ongoing Clinical Trials Overview
5.4 MFB Fertility Inc Company Overview
5.4.1 MFB Fertility Inc Pipeline Products & Ongoing Clinical Trials Overview
5.5 NG Biotech Company Overview
5.5.1 NG Biotech Pipeline Products & Ongoing Clinical Trials Overview
5.6 OPKO Health Inc Company Overview
5.6.1 OPKO Health Inc Pipeline Products & Ongoing Clinical Trials Overview
5.7 Pop Test LLC Company Overview
5.7.1 Pop Test LLC Pipeline Products & Ongoing Clinical Trials Overview
5.8 PragmaDX Inc Company Overview
5.8.1 PragmaDX Inc Pipeline Products & Ongoing Clinical Trials Overview
5.9 Quidel Corp Company Overview
5.9.1 Quidel Corp Pipeline Products & Ongoing Clinical Trials Overview

6 Female Fertility Rapid Tests - Recent Developments
6.1 Aug 08, 2019: Quidel reports second quarter 2019 Financial Results
6.2 May 28, 2019: True Diagnostics receives FDA 510(k) clearance to market VeriClear Digital Test Device for early result pregnancy
6.3 May 14, 2019: Sekisui Diagnostics invests $1.9 million in Microbial Biopharma CDMO business
6.4 May 08, 2019: Quidel reports first quarter 2019 financial results
6.5 Apr 01, 2019: Mologic expands US and UK operations
6.6 Feb 27, 2019: Sekisui Diagnostics expanding again and adding more jobs
6.7 Feb 13, 2019: Quidel Reports Fourth Quarter and Full Year 2018 Financial Results
6.8 Jan 07, 2019: Quidel Announces Preliminary Revenue for Fourth Quarter 2018
6.9 Nov 06, 2018: Quidel reports third quarter 2018 financial results

7 Appendix
7.1 Methodology
7.2 About the author
7.3 Contact Us
7.4 Disclaimer

List of Tables
Table 1: Female Fertility Rapid Tests - Pipeline Products by Stage of Development
Table 2: Female Fertility Rapid Tests - Pipeline Products by Segment
Table 3: Female Fertility Rapid Tests - Pipeline Products by Territory
Table 4: Female Fertility Rapid Tests - Pipeline Products by Regulatory Path
Table 5: Female Fertility Rapid Tests - Pipeline Products by Estimated Approval Date
Table 6: Female Fertility Rapid Tests Companies - Pipeline Products by Stage of Development
Table 7: Female Fertility Rapid Tests - Pipeline Products by Stage of Development
Table 8: BBB Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 19: Bio-AMD Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 24: ET Healthcare Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 35: MFB Fertility Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 38: NG Biotech Pipeline Products & Ongoing Clinical Trials Overview
Table 47: OPKO Health Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 50: Pop Test LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 53: PragmaDX Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 56: Quidel Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 59: Glossary

List of Figures
Figure 1: Female Fertility Rapid Tests - Pipeline Products by Stage of Development
Figure 2: Female Fertility Rapid Tests - Pipeline Products by Segment
Figure 3: Female Fertility Rapid Tests - Pipeline Products by Territory
Figure 4: Female Fertility Rapid Tests - Pipeline Products by Regulatory Path
Figure 5: Female Fertility Rapid Tests - Pipeline Products by Estimated Approval Date

Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • BBB Technologies Inc
  • Bio-AMD Inc
  • ET Healthcare Inc
  • MFB Fertility Inc
  • NG Biotech
  • OPKO Health Inc
  • Pop Test LLC
  • PragmaDX Inc
  • Quidel Corp
Note: Product cover images may vary from those shown
Adroll
adroll